Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.33
+0.02001.53%
Post-market: 1.340.0093+0.70%19:30 EDT
Volume:250.26K
Turnover:338.13K
Market Cap:33.91M
PE:-3.05
High:1.39
Open:1.33
Low:1.31
Close:1.31
52wk High:2.23
52wk Low:0.8500
Shares:25.50M
Float Shares:24.90M
Volume Ratio:0.93
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4355
EPS(LYR):-0.6263
ROE:-89.97%
ROA:-50.46%
PB:3.70
PE(LYR):-2.12

Loading ...

Nanoviricides, Inc : Noble Capital Initiates Coverage with Outperform Rating; Target Price $6

THOMSON REUTERS
·
Jul 06

Nanoviricides Says FDA Grants Rare Pediatric Disease Designation for Nv-387 Measles Treatment

Reuters
·
Jun 29

NanoViricides ships NV-387 oral gummies to DR Congo for Phase II mpox trial

Reuters
·
Jun 22

NanoViricides files to sell 1.33M shares of common stock for holders

TIPRANKS
·
Jun 16

NanoViricides announces proposal approved by Pillar Committee in DRC

TIPRANKS
·
Jun 15

NanoViricides proposes Phase II trial of NV-387 gummies in Ebola

TIPRANKS
·
Jun 08

NanoViricides Files for $50 Million Mixed Shelf Offering

MT Newswires Live
·
Jun 06

NanoViricides files $50M mixed securities shelf

TIPRANKS
·
Jun 06

NanoViricides - Files to Offer up to $50 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jun 06

Top Premarket Gainers

MT Newswires Live
·
May 27

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27

NanoViricides says NV-387 oral gummies ready to ship to DRC for Phase II mpox trial amid Ebola outbreak

Reuters
·
May 26

NanoViricides Highlights NV-387 Strategy for Ebola Outbreak

TIPRANKS
·
May 21

NanoViricides says NV-387 candidates expected to work against Congo Bundibugyo Ebola strain

Reuters
·
May 21

NanoViricides Completes $2 Million Registered Direct Offering

TIPRANKS
·
May 21

NanoViricides closes US$2 million registered direct offering priced at US$1.5 share

Reuters
·
May 19

EXPLAINER-What do we know about the Bundibugyo strain of the Ebola virus?

Reuters
·
May 19

NanoViricides emphasizes need for Ebolavirus antiviral drug

TIPRANKS
·
May 18

NanoViricides prices US$2 million registered direct offering with warrants

Reuters
·
May 15

NanoViricides Q3 FY26 net loss narrows to $1.99 million; R&D expenses rise to $1.29 million

Reuters
·
May 15